Development of a hypoxia-inducible cytosine deaminase expression vector for gene-directed prodrug cancer therapy. [electronic resource]
Producer: 20050617Description: 276-83 p. digitalISSN:- 0929-1903
- Blotting, Western
- Cell Hypoxia -- physiology
- Cell Line, Tumor
- Cytosine Deaminase -- genetics
- Enhancer Elements, Genetic -- genetics
- Erythropoietin -- genetics
- Flucytosine -- metabolism
- Fluorouracil -- metabolism
- Genetic Therapy -- methods
- Genetic Vectors -- genetics
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit
- Neoplasms -- drug therapy
- Prodrugs -- therapeutic use
- Simian virus 40
- Transcription Factors -- genetics
- Transfection
- Tumor Stem Cell Assay
- Yeasts
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.